PMID: 9451465Feb 6, 1998Paper

Glibenclamide: an old drug with a novel mechanism of action?

Acta Diabetologica
L Luzi, G Pozza

Abstract

This review is meant to give to the readers an overview of the pharmacokinetics, pharmacodynamics, mechanism(s) of action and therapeutical indications of the sulfonylurea compound glibenclamide, which is a cardinal drug in the treatment of type 2 diabetes mellitus. Data produced in our own laboratory over the past 15 years will be presented, along with reference to the main literature in the field. As pharmacokinetics is concerned, special emphasis will be placed on the detrimental effect of hyperglycemia in the intestinal absorption of this class of drugs. Both beta-cell and extrapancreatic effects of glibenclamide will be highlighted. The mechanism of action of the drug consists in the inhibition of the ATP-sensitive K+ channels, which leads to depolarization of the cells and insulin secretion. Based on the same mechanism are also the extrapancreatic action of the drug at the liver, skeletal muscle, heart muscle and smooth muscle sites. The newly discovered possible physiological actions of the C-peptide molecule [suggesting a stimulatory effect of C-peptide on the Na+, K+ (ATPase) pump and on diabetic complications], cast a new light on all therapeutic approaches (like sulfonylurea class of compounds and whole pancreas or i...Continue Reading

Citations

Jul 1, 2009·International Journal of Molecular Sciences·Rajangam UdayakumarChang Won Choi
Sep 10, 2014·European Journal of Medicinal Chemistry·Alessandra MascarelloRicardo José Nunes
May 11, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Pasupuleti Visweswara RaoSiew Hua Gan
Nov 3, 2012·Expert Opinion on Pharmacotherapy·Elizabeth Mary LamosStephen N Davis
Mar 3, 2015·Expert Opinion on Investigational Drugs·Ye XiongMichael Chopp
Oct 25, 2006·Clinical and Experimental Hypertension : CHE·Matthias HuberReinhold Kreutz
Dec 22, 2004·The Journal of Physiology·Naoki HorikawaHideki Sakai
Aug 14, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Enayat A OmaraSayed A El-Toumy
Jun 9, 2009·Journal of Ethnopharmacology·Maria G CamposRicardo Reyes-Chilpa
May 17, 2005·British Journal of Pharmacology·Jolanta SkalskaAdam Szewczyk
Dec 12, 2012·Journal of Diabetes·Adeleke Clement AdebajoEugene Joseph Verspohl
Oct 7, 2004·Biochemical and Biophysical Research Communications·James M LenhardDana T Minnick
Dec 7, 2013·Chemico-biological Interactions·Carolina Serra-BarcellonaSara S Sánchez
Oct 31, 2002·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·O HnatyszynC Acevedo
Aug 26, 2017·Phytotherapy Research : PTR·Cicero Diego Almino MenezesIrwin Rose Alencar de Menezes
Sep 15, 2004·The Journal of Pharmacology and Experimental Therapeutics·So-Young Lee, Chin O Lee
Oct 20, 2019·Drug Safety - Case Reports·Yasunori NaganoNaoko Iwahashi Kondo
May 29, 2020·The Journal of Physiology·Marcos P RochaIgor A Fernandes
Dec 11, 2019·International Journal of Molecular Sciences·Christiane KlecWolfgang F Graier
Oct 22, 2002·American Journal of Physiology. Endocrinology and Metabolism·Takashi MikiSusumu Seino
Apr 20, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Khaled BenchoulaHesham El-Seedi
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Eleonora MezzaromaStefano Toldo
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mohamed BouhrimMohamed Bnouham
Jun 14, 2014·Bioorganic Chemistry·Koyel KarB R Prashantha Kumar
Jan 30, 2021·Protein and Peptide Letters·Victor Hugo Dantas GuimarãesSérgio Henrique Sousa Santos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.